(Q55467664)

English

Cancer: mixing cocktails.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/17960228

Cancer: mixing cocktails. (English)

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/17960228

author name string

Charles L Sawyers

1

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/17960228

language of work or name

0 references

publication date

1 October 2007

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/17960228

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/17960228

449

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/17960228

993-996

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/17960228

7165

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/17960228

https://scigraph.springernature.com/pub.10.1038/449993a

0 references

Opportunities and challenges in the development of kinase inhibitor therapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2F449993A

7 January 2021

based on heuristic

inferred from DOI database lookup

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

https://api.crossref.org/works/10.1038%2F449993A

7 January 2021

based on heuristic

inferred from DOI database lookup

Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies

1 reference

https://api.crossref.org/works/10.1038%2F449993A

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

1 reference

https://api.crossref.org/works/10.1038%2F449993A

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of chronic myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2F449993A

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants

1 reference

https://api.crossref.org/works/10.1038%2F449993A

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2F449993A

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency

1 reference

https://api.crossref.org/works/10.1038%2F449993A

7 January 2021

based on heuristic

inferred from DOI database lookup

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

1 reference

https://api.crossref.org/works/10.1038%2F449993A

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/449993A

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/17960228

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/17960228

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55467664&oldid=1455184984"